Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 5 of 23
evoxx technologies
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2013
Hold
4yr
Exit
2017
Fusion Antibodies
Co-Fund NI
United KingdomSector
Biotech
InvestorClarendon Fund Managers
Entry
2013
Hold
4yr
Exit
2017
Horizon Discovery
Parkwalk Opportunities EIS Fund
UKSector
Biotech
InvestorParkwalk Advisors
Entry
2013
Hold
4yr
Exit
2017
Oncopeptides
Industrifonden Evergreen
SwedenSector
Biotech
InvestorIndustrifonden
Entry
2013
Hold
4yr
Exit
2017
Oncopeptides AB
HealthCap VI
SE
Sector
Biotech
InvestorHealthCap
Entry
2013
Hold
4yr
Exit
2017
BRAIN Biotech
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2006
Hold
10yr
Exit
2016
Ganymed Pharmaceuticals
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2001
Hold
15yr
Owners
2
Exit
2016
Atopix Therapeutics
Wellington Partners Life Sciences
United KingdomSector
Biotech
InvestorWellington Partners
Entry
2013
Hold
3yr
Exit
2016
B.R.A.I.N. AG
Technologiefonds Hessen
GermanySector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2014
Hold
2yr
Exit
2016
Cereno Scientific
GU Ventures Evergreen
SwedenSector
Biotech
InvestorGU Ventures
Entry
2012
Hold
4yr
Exit
2016
CHASE Pharmaceuticals
BioDiscovery 4
United StatesSector
Biotech
InvestorAndera Partners
Entry
2014
Hold
2yr
Exit
2016
Cormorant Pharmaceuticals
Flerie Invest
SwedenSector
Biotech
InvestorFlerie
Entry
2012
Hold
4yr
Exit
2016
GENEPEP
Naxicap Legacy Funds
SwitzerlandSector
Biotech
InvestorNaxicap Partners
Entry
2007
Hold
9yr
Exit
2016
GenSight Biologics S.A.
HealthCap VI
FranceSector
Biotech
InvestorHealthCap
Entry
2015
Hold
1yr
Exit
2016
Noxxon
BioDiscovery 2
FranceSector
Biotech
InvestorAndera Partners
Entry
2007
Hold
9yr
Exit
2016
SynAct Pharma
CAPNOVA
DenmarkSector
Biotech
InvestorCapnova
Entry
2012
Hold
4yr
Exit
2016
Tobira Therapeutics
BioDiscovery 3
FranceSector
Biotech
InvestorAndera Partners
Entry
2009
Hold
7yr
Exit
2016
LGC
Cinven Seventh Fund
UKSector
Biotech
InvestorCinven
Entry
2010
Hold
11yr
Owners
4
BioGenes
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2003
Hold
12yr
Exit
2015
SuppreMol
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2006
Hold
9yr
Owners
2
Exit
2015
Alzinova
GU Ventures Evergreen
SwedenSector
Biotech
InvestorGU Ventures
Entry
2011
Hold
4yr
Exit
2015
Cantargia
Sunstone Life Science Ventures III
SwedenSector
Biotech
InvestorSunstone Life Science Ventures
Entry
2013
Hold
2yr
Exit
2015
Cerenis Therapeutics Holding SA
HealthCap V
FranceSector
Biotech
InvestorHealthCap
Entry
2005
Hold
10yr
Exit
2015
Glycovaxin
BioDiscovery 3
FranceSector
Biotech
InvestorAndera Partners
Entry
2009
Hold
6yr
Exit
2015
Nordic Nanovector AS
HealthCap VI
NO
Sector
Biotech
InvestorHealthCap
Entry
2013
Hold
2yr
Exit
2015
Phenex
LBBW VC Evergreen Vehicle
GermanySector
Biotech
InvestorLBBW Venture Capital
Entry
2005
Hold
10yr
Exit
2015
Pieris Pharmaceuticals
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2001
Hold
14yr
Exit
2015
Toleranzia
GU Ventures Evergreen
SwedenSector
Biotech
InvestorGU Ventures
Entry
2011
Hold
4yr
Exit
2015
Vivoryon
BioDiscovery 3
FranceSector
Biotech
InvestorAndera Partners
Entry
2009
Hold
5yr
Exit
2014
Covagen
BioDiscovery 3
BelgiumSector
Biotech
InvestorAndera Partners
Entry
2010
Hold
4yr
Owners
2
Exit
2014
Algeta ASA
HealthCap V
NorwaySector
Biotech
InvestorHealthCap
Entry
2005
Hold
9yr
Exit
2014
Cellectis
Odyssee Venture Funds
FranceSector
Biotech
InvestorOdyssée Venture
Entry
2002
Hold
12yr
Exit
2014
Follicum
Sunstone Life Science Ventures III
SwedenSector
Biotech
InvestorSunstone Life Science Ventures
Entry
2012
Hold
2yr
Exit
2014
Forward Pharma
Nordic Biotech K/S
DenmarkSector
Biotech
InvestorNordic Biotech Advisors
Entry
2006
Hold
8yr
Exit
2014
GenKyoTex
BioDiscovery 3
FranceSector
Biotech
InvestorAndera Partners
Entry
2011
Hold
3yr
Exit
2014
Oncoethix
BioDiscovery 4
BelgiumSector
Biotech
InvestorAndera Partners
Entry
2013
Hold
1yr
Exit
2014
Pieris
Sobera Capital Fund II
United StatesSector
Biotech
InvestorSobera Capital
Entry
2013
Hold
1yr
Exit
2014
Ultragenyx
HealthCap VI
United StatesSector
Biotech
InvestorHealthCap
Entry
2011
Hold
3yr
Exit
2014
Ultragenyx Pharmaceuticals Inc.
HealthCap VI
United StatesSector
Biotech
InvestorHealthCap
Entry
2011
Hold
3yr
Exit
2014
Aros Applied Biotechnology
CAPNOVA
DenmarkSector
Biotech
InvestorCapnova
Entry
2000
Hold
13yr
Exit
2013
bluebird bio
TVM Life Science Ventures
United StatesSector
Biotech
InvestorTVM Capital Life Science
Entry
2004
Hold
9yr
Exit
2013
EOS (Ethical Oncology Science)
Principia Fund
ItalySector
Biotech
InvestorPrincipia SGR
Entry
2009
Hold
4yr
Exit
2013
Okairos
Boehringer Ingelheim Venture Fund
SwitzerlandSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2011
Hold
2yr
Exit
2013
Action Pharma
CAPNOVA
DenmarkSector
Biotech
InvestorCapnova
Entry
2002
Hold
10yr
Exit
2012
Corimmun
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2006
Hold
6yr
Exit
2012
Ferrokin Biosciences Inc.
HealthCap VI
United StatesSector
Biotech
InvestorHealthCap
Entry
2009
Hold
3yr
Exit
2012
BioVex
Ysios BioFund I
USSector
Biotech
InvestorYsios Capital Partners
Entry
2009
Hold
2yr
Exit
2011
KINAXO
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2006
Hold
5yr
Exit
2011
BioInvent
Industrifonden Evergreen
SwedenSector
Biotech
InvestorIndustrifonden
Entry
1997
Hold
13yr
Exit
2010
Tengion Inc
HealthCap IV
United StatesSector
Biotech
InvestorHealthCap
Entry
2003
Hold
7yr
Exit
2010